Clinical Trials
3 trialsNCT01002248 2018-02-09
Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
AEterna Zentaris
Phase 3 Terminated
NCT00058214 2015-02-23
Perifosine in Treating Patients With Recurrent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00062387 2013-06-03
Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Terminated